Risk Assessment of Indirect Exposure to the Environment in the Gastrointestinal Endoscopy Center

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Apr 8, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the potential risks of infection that can happen when patients and medical staff come into contact with surfaces and equipment in the gastrointestinal endoscopy center. The researchers are using a safe substance called Vitamin B2 to help simulate and understand how these environmental objects might contribute to the spread of germs during procedures like gastroscopy, which is a type of examination of the digestive system.

To participate in this study, patients must be scheduled for a gastroscopy at the Beijing Union Medical College Hospital during the trial period. There are some conditions that could exclude someone from joining, such as being allergic to Vitamin B2 or having serious health issues that make it hard to tolerate the examination. If you decide to take part, you can expect to help researchers learn more about infection control during these important medical procedures, which could ultimately benefit future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • During the study period, patients who were treated in the digestive endoscopy center of Beijing Union Medical College Hospital and planned to undergo gastroscopy. Age and gender are not limited temporarily.
• Exclusion Criteria:
• • Allergic to medical non-toxic fluorescent agent: Vitamin B2 aqueous solution.
• • Poor general condition, including severe cardiopulmonary disease, difficult to tolerate examination, and coagulation disorders.
• • Patients with contraindications to endoscopy.